DR Technology to Be Used in Orthopedic Clinical Trials for Roentgen Stereophotogrametric Analysis

A standardized digital radiology (DR) component for integration into an imaging system suite is currently under development for conducting orthopedic clinical trials for roentgen stereophotogrametric analysis (RSA).

Imaging Dynamics Co., Ltd. (IDC; Calgary, Canada), a developer of digital radiography (DR) systems, reported that Halifax Biomedical, Inc. (HBI; Halifax, Canada) has selected IDC's X1590 as the DR system to be used in the trail.

Under a Canadian federal grant, Halifax Biomedical will interface its calibration technology with IDC's DR system and analytic software from Medis Specials (Leiden, The Netherlands) to create the first standardized, digital RSA suite. The system, which was presented at the American Academy of Orthopedic Surgeons (AAOS) conference held in San Francisco (CA, USA), March 5-7, 2008, will measure the stability of orthopedic implants to a fraction of a millimeter.

"We carefully evaluated every available digital radiography system and only IDC technology could meet our rigorous requirements,” said Chad Munro, president of Halifax Biomedical. He added, "IDC's X-Series clearly contains the best technology for this type of precise, specialized application.”

Halifax Biomedical provides specialized contract research services and develops RSA-related imaging equipment for orthopedic clinical trials. The product suite currently under development is designed to measure the stability of orthopedic implants. Identifying the migration of implants into bone can be predictive of future failure of the implant due to aseptic loosening. RSA is also useful in assessing spinal fusion and fracture healing.

Results from the first test of the product suite will be the backbone that allows expansion to a larger clinical network enabling remote collaboration on standardized imaging systems.

Halifax Biomedical is a contract research organization specializing in RSA research services and equipment, including the RSA suite. HBI is currently supporting eight clinical RSA trials in Halifax.

IDC is a medical technology company involved in the fast-growing field of DR technology. IDC's X-Series of direct capture technology replaces conventional film-based X-rays and provides a cost-effective alternative to cassette-based film or computed radiography (CR) systems. Each IDC DR system provides high-resolution radiographic images in the digital format required for current electronic medical record networks, all without the use of film, environmentally harmful chemicals, cassettes, or expensive imaging plates.


Related Links:
IDC
Halifax Biomedical